Coeliac disease in the COVID-19 pandemic: does HLA have a protective effect?

Figures & data

Figure 1. Questionnaire.

Table 1. Results of the interview carried out on all patients. 

Results of the interview
Total patients	n.191
Males	30.4 % (n.58)
Females	69.6 % (n.133)
Coeliacs in activity	22 % (n.42)
Coeliacs in remission	78% (n.149)
DQ2	14.1% (n.27)
DQ8	2.6% (n.5)
DQ2–DQ8	2.1% (n.4)
Genetics not detected	81.2% (n.155)
Patients who consider themselves more vulnerable to COVID-19	15.2% (n.29)
Patients who were afraid to go to the hospital for a check-up	28.3% (n.54)
Patients who were adversely affected by the closure of the clinics	22.5% (n.43)
Patients who have had difficulty managing the diet	5.8% (n.11)
Patients who have had difficulty searching for specific foods	9.9% (n.19)
Patients who have other autoimmune diseases	29.3% (56%)
Patients who have had contact with people who have been diagnosed with COVID-19	26.7% (n.51)
Patients who have experienced flu-like symptoms	17.3% (n.33)
Patients who have undergone diagnostic tests for COVID-19	64.9% (n.124)
They were diagnosed with COVID-19	5.8% (n.11)
COVID-19 positive patients who have had a fever	5.2% (n.10)
COVID-19 positive patients who have been hospitalized	0
COVID-19 positive patients who have been admitted to intensive care	0

Data availability statement

Data are stored in our University, Sapienza University of Rome, and are available upon request.